NEUP — NEUPHORIA THERAPEUTICS INC
What is a 13F filing? Who files one and when · What 13F filings can't tell you
Last updated: 2026-11-14 · Source: SEC EDGAR Form 13F-HR
As of Q2 2026, 23 SEC-registered investment managers reported holding NEUP (NEUPHORIA THERAPEUTICS INC) in their latest 13F filings, with a combined reported value of $8.93M across 2.04M shares. That is +9.8% by share count (+153.15K shares) versus the previous quarter, while reported value moved +17.8%. Ownership is concentrated: the five largest holders account for 78.3% of reported value and the top ten for 90.7%.
Compared with the prior quarter, 8 opened new positions, 4 added to existing stakes, 2 trimmed, 3 exited entirely. 13F holdings are quarter-end snapshots, so these moves reflect positioning as of Q2 2026, not real-time trading.
Major shareholders of NEUPHORIA THERAPEUTICS INC (NEUP) include Lynx1 Capital Management LP, AdvisorShares Investments LLC, Shay Capital LLC, ranked by reported 13F value among the 37 institutional holders on this page.
NEUP is classified in the Health Care sector.
All figures on this page are computed from SEC Form 13F quarterly filings. 13F filers disclose long positions of $100,000 or more within 45 days of quarter end; short positions, options overlays and intra-quarter trades are not included, so treat the numbers as a quarterly snapshot of institutional ownership rather than real-time positioning.
Institutional Ownership by Quarter
| Quarter | Funds holding | Shares | Value | QoQ Net Change |
|---|---|---|---|---|
| Q3 2026 | 10 | 599.32K | $2.13M | +11.6% |
| Q2 2026 | 23 | 2.04M | $8.93M | +9.8% |
| Q1 2026 | 18 | 1.66M | $6.75M | +2.9% |
| Q4 2025 | 21 | 1.47M | $5.69M | +80.6% |
| Q3 2025 | 15 | 183.84K | $2.17M | -11.8% |
| Q2 2025 | 8 | 148.21K | $1.05M | -1.7% |
| Q1 2025 | 6 | 135.91K | $778.68K | -1.2% |
| Q4 2024 | 7 | 79.72K | $273.44K | — |
Over the 8 quarters shown, institutional share counts increased 652% in aggregate (Q4 2024 → Q3 2026); the largest single-quarter swing was Q4 2025 (+80.6%).
Top Institutional Holders (Q3 2026) — 10 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 312.89K | $1.11M | 0.14% | Add | |
| 173.49K | $617.62K | 0.00% | Hold | |
| 50.64K | $180.26K | 0.00% | Add | |
| 33.81K | $120.35K | 0.00% | Hold | |
| 18.17K | $64.69K | 0.00% | Add | |
| 10.03K | $35.70K | 0.00% | Hold | |
| 224 | $797 | 0.00% | Reduce | |
| 58 | $207 | 0.00% | Hold | |
| 16 | $57 | 0.00% | New | |
| 3 | $11 | 0.00% | New |
Holder history for earlier quarters, one table per quarter: Back to the Top 25 holders
Q2 2026 — 23 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 875.33K | $3.83M | 0.44% | Hold | |
| 252.91K | $1.11M | 0.13% | Add | |
| 173.49K | $758.14K | 0.00% | New | |
| 155.82K | $680.94K | 0.09% | Add | |
| 142.23K | $621.54K | 0.00% | Hold | |
| 72.56K | $317.08K | 0.00% | Add | |
| 49.52K | $216.38K | 0.00% | New | |
| 49.52K | $216.38K | 0.00% | Reduce | |
| 47.44K | $207.33K | 0.03% | Hold | |
| 33.81K | $147.73K | 0.00% | Add | |
| 30.00K | $131.10K | 0.01% | Hold | |
| 26.50K | $115.00K | 0.05% | Hold | |
| 25.50K | $111.44K | 0.00% | New | |
| 23.09K | $100.90K | 0.00% | New | |
| 22.86K | $99.00K | 0.00% | New | |
| 14.90K | $65.13K | 0.00% | New | |
| 14.00K | $61.18K | 0.00% | Hold | |
| 11.22K | $49.04K | 0.00% | Hold | |
| 10.61K | $46.37K | 0.00% | New | |
| 10.03K | $43.82K | 0.01% | Hold | |
| 2.12K | $9.25K | 0.00% | Reduce | |
| 58 | $254 | 0.00% | Hold | |
| 3 | $13 | 0.00% | New |
Q1 2026 — 18 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 875.33K | $3.56M | 0.56% | Hold | |
| 155.37K | $632.34K | 0.12% | Add | |
| 151.01K | $614.61K | 0.10% | Reduce | |
| 142.18K | $578.68K | 0.00% | New | |
| 76.73K | $312.28K | 0.13% | New | |
| 52.01K | $211.67K | 0.00% | Add | |
| 47.44K | $193.09K | 0.02% | Hold | |
| 33.59K | $136.71K | 0.00% | New | |
| 30.00K | $122.10K | 0.01% | Hold | |
| 26.50K | $107.00K | 0.06% | Hold | |
| 19.33K | $78.68K | 0.00% | New | |
| 14.00K | $56.98K | 0.00% | Hold | |
| 12.03K | $49.00K | 0.00% | New | |
| 11.22K | $45.67K | 0.00% | Hold | |
| 10.03K | $40.81K | 0.01% | Hold | |
| 2.32K | $9.43K | 0.00% | Add | |
| 202 | $822 | 0.00% | Hold | |
| 58 | $236 | 0.00% | Hold |
Q4 2025 — 21 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 875.23K | $3.40M | 0.69% | New | |
| 169.06K | $655.95K | 0.10% | New | |
| 134.19K | $520.67K | 0.09% | Add | |
| 50.00K | $194.00K | 0.05% | Add | |
| 47.44K | $184.08K | 0.02% | New | |
| 30.00K | $116.40K | 0.01% | New | |
| 26.50K | $102.00K | 0.04% | New | |
| 20.95K | $81.29K | 0.00% | Hold | |
| 17.30K | $67.14K | 0.00% | Add | |
| 16.60K | $64.40K | 0.00% | Add | |
| 14.75K | $57.23K | 0.00% | New | |
| 14.00K | $54.32K | 0.00% | New | |
| 13.40K | $52.00K | 0.03% | Add | |
| 12.01K | $46.59K | 0.00% | New | |
| 11.21K | $43.48K | 0.00% | New | |
| 10.03K | $38.91K | 0.01% | Hold | |
| 1.65K | $6.41K | 0.00% | Reduce | |
| 1.40K | $5.43K | 0.00% | Add | |
| 202 | $783 | 0.00% | Add | |
| 58 | $225 | 0.00% | Add | |
| 18 | $70 | 0.00% | Add |
Q3 2025 — 15 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 58.56K | $690.46K | 0.11% | Reduce | |
| 21.45K | $252.92K | 0.09% | New | |
| 20.95K | $247.00K | 0.00% | New | |
| 18.33K | $216.10K | 0.00% | New | |
| 18.33K | $216.10K | 0.00% | New | |
| 15.67K | $184.74K | 0.00% | New | |
| 12.98K | $153.01K | 0.00% | New | |
| 10.03K | $118.22K | 0.05% | Hold | |
| 4.91K | $57.87K | 0.04% | New | |
| 2.17K | $25.56K | 0.00% | New | |
| 410 | $4.83K | 0.00% | New | |
| 33 | $389 | 0.00% | Hold | |
| 17 | $201 | 0.00% | Add | |
| 7 | $83 | 0.00% | Hold | |
| 2 | $24 | 0.00% | New |
Q2 2025 — 8 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 67.73K | $480.90K | 0.09% | Reduce | |
| 45.81K | $325.22K | 0.09% | Hold | |
| 14.61K | $103.70K | 0.00% | New | |
| 10.03K | $71.19K | 0.03% | Hold | |
| 10.00K | $71.00K | 0.00% | Hold | |
| 33 | $234 | 0.00% | Reduce | |
| 7 | $50 | 0.00% | Hold | |
| 1 | $7 | 0.00% | New |
New Positions (Q2 2026)
- VANGUARD CAPITAL MANAGEMENT LLC 173.49K sh · $758.14K
- GEODE CAPITAL MANAGEMENT, LLC 49.52K sh · $216.38K
- Renaissance Technologies 25.50K sh · $111.44K
- XTX Topco Ltd 23.09K sh · $100.90K
- HRT FINANCIAL LP 22.86K sh · $99.00K
- JANE STREET GROUP, LLC 14.90K sh · $65.13K
- Northern Trust Corp 10.61K sh · $46.37K
- Caitong International Asset Management Co., Ltd 3 sh · $13
Fully Exited (vs previous quarter)
- Squadron Capital Management LLC sold 76.73K sh · $312.28K
- Virtu Financial LLC sold 12.03K sh · $49.00K
- RHUMBLINE ADVISERS sold 202 sh · $822
Fund Position History — shares by quarter (top 20 funds)
| Fund | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 |
|---|---|---|---|---|---|---|---|---|
| AdvisorShares Investments LLC | 312.89K | 252.91K | 155.37K | 134.19K | 58.56K | 67.73K | 69.66K | — |
| VANGUARD CAPITAL MANAGEMENT LLC | 173.49K | 173.49K | — | — | — | — | — | — |
| Geode Capital Management | 50.64K | 49.52K | 52.01K | 17.30K | 12.98K | — | — | — |
| VANGUARD FIDUCIARY TRUST CO | 33.81K | 33.81K | 33.59K | — | — | — | — | — |
| JANE STREET GROUP, LLC | 18.17K | 14.90K | — | 16.60K | 15.67K | — | — | 13.31K |
| Merck & Co., Inc. | 10.03K | 10.03K | 10.03K | 10.03K | 10.03K | 10.03K | 10.03K | 10.03K |
| UBS Group AG | 224 | 2.12K | 2.32K | 1.65K | 2.17K | — | — | 2.98K |
| Morgan Stanley | 58 | 58 | 58 | 58 | 7 | 7 | 7 | 7 |
| Fidelity Management & Research (FMR) | 16 | — | — | — | 2 | — | — | — |
| BARCLAYS PLC | 3 | — | — | — | — | — | — | — |
| Lynx1 Capital Management LP | — | 875.33K | 875.33K | 875.23K | — | 45.81K | 45.81K | 45.81K |
| Shay Capital LLC | — | 155.82K | 151.01K | 169.06K | — | — | — | — |
| Balyasny Asset Management | — | 142.23K | 142.18K | — | — | — | — | — |
| Citadel Advisors | — | 72.56K | 19.33K | — | — | 14.61K | — | — |
| Squadron Capital Management LLC | — | — | 76.73K | — | — | — | — | — |
| DIADEMA PARTNERS LP | — | — | — | 50.00K | 21.45K | — | — | — |
| Vanguard Group | — | — | — | 20.95K | 20.95K | — | — | — |
| GEODE CAPITAL MANAGEMENT, LLC | — | 49.52K | — | — | — | — | — | — |
| MILLENNIUM MANAGEMENT LLC | — | — | — | — | 18.33K | — | — | — |
| Ikarian Capital, LLC | — | 47.44K | 47.44K | 47.44K | — | — | — | — |
▲ Bought Low (fund opened/added, stock rose ≥5% next quarter) ▼ Sold High (fund reduced, stock fell ≥5% next quarter)
Drag / scroll to zoom · Default shows the most recent year · Annotations come from quarterly fund actions in 13F filings · Hover a marker for details
FAQ
Which funds hold NEUP?
As of 2026-Q2, 23 institutional funds reported holding NEUP (NEUPHORIA THERAPEUTICS INC) in SEC 13F filings, with a combined reported value of $8.93M.
How many shares of NEUP do institutions own?
13F filers reported 2.04M shares of NEUP, worth $8.93M in aggregate at the end of 2026-Q2.
Is institutional ownership of NEUP rising or falling?
Share counts moved +9.8% versus the prior quarter — accumulation.
Who are the top institutional holders of NEUP?
The largest 13F holders are Lynx1 Capital Management LP, AdvisorShares Investments LLC, Shay Capital LLC, Balyasny Asset Management, VANGUARD CAPITAL MANAGEMENT LLC; the top 25 are ranked at the top of this page.
Who are the major shareholders of NEUPHORIA THERAPEUTICS INC?
The major shareholders of NEUPHORIA THERAPEUTICS INC (NEUP) by reported 13F value are Lynx1 Capital Management LP, AdvisorShares Investments LLC, Shay Capital LLC, Balyasny Asset Management, VANGUARD CAPITAL MANAGEMENT LLC, among 37 institutional holders.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.